Asensus Surgical ASXC Stock
Asensus Surgical Price Chart
Asensus Surgical ASXC Financial and Trading Overview
| Asensus Surgical stock price | 0.35 USD |
| Previous Close | 0.54 USD |
| Open | 0.55 USD |
| Bid | 0.55 USD x 900 |
| Ask | 0.58 USD x 900 |
| Day's Range | 0.54 - 0.56 USD |
| 52 Week Range | 0.28 - 1.18 USD |
| Volume | 502.09K USD |
| Avg. Volume | 728.7K USD |
| Market Cap | 131.71M USD |
| Beta (5Y Monthly) | 1.715492 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.65 USD |
ASXC Valuation Measures
| Enterprise Value | 78.22M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.037037 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 18.823254 |
| Price/Book (mrq) | 1.6516516 |
| Enterprise Value/Revenue | 11.179 |
| Enterprise Value/EBITDA | -1.117 |
Trading Information
Asensus Surgical Stock Price History
| Beta (5Y Monthly) | 1.715492 |
| 52-Week Change | 48.64% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.18 USD |
| 52 Week Low | 0.28 USD |
| 50-Day Moving Average | 0.62 USD |
| 200-Day Moving Average | 0.56 USD |
ASXC Share Statistics
| Avg. Volume (3 month) | 728.7K USD |
| Avg. Daily Volume (10-Days) | 599.62K USD |
| Shares Outstanding | 239.47M |
| Float | 234.89M |
| Short Ratio | 16.88 |
| % Held by Insiders | 1.15% |
| % Held by Institutions | 10.83% |
| Shares Short | 11.23M |
| Short % of Float | 4.78% |
| Short % of Shares Outstanding | 4.68% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:13 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1121.89% |
| Gross Margin | -71.44% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -37.29% |
| Return on Equity (ttm) | -68.23% |
Income Statement
| Revenue (ttm) | 7M USD |
| Revenue Per Share (ttm) | 0.03 USD |
| Quarterly Revenue Growth (yoy) | -8.40% |
| Gross Profit (ttm) | -3785000 USD |
| EBITDA | -70037000 USD |
| Net Income Avi to Common (ttm) | -78651000 USD |
| Diluted EPS (ttm) | -0.33 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 56.43M USD |
| Total Cash Per Share (mrq) | 0.24 USD |
| Total Debt (mrq) | 5.34M USD |
| Total Debt/Equity (mrq) | 6.7 USD |
| Current Ratio (mrq) | 6.579 |
| Book Value Per Share (mrq) | 0.333 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -60242000 USD |
| Levered Free Cash Flow (ttm) | -31867124 USD |
Profile of Asensus Surgical
| Country | United States |
| State | NC |
| City | Durham |
| Address | 1 TW Alexander Drive |
| ZIP | 27703 |
| Phone | 919-765-8400 |
| Website | https://www.asensus.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 183 |
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures. Its products also comprise instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is headquartered in Durham, North Carolina.
Q&A For Asensus Surgical Stock
What is a current ASXC stock price?
Asensus Surgical ASXC stock price today per share is 0.35 USD.
How to purchase Asensus Surgical stock?
You can buy ASXC shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Asensus Surgical?
The stock symbol or ticker of Asensus Surgical is ASXC.
Which industry does the Asensus Surgical company belong to?
The Asensus Surgical industry is Medical Devices.
How many shares does Asensus Surgical have in circulation?
The max supply of Asensus Surgical shares is 272.84M.
What is Asensus Surgical Price to Earnings Ratio (PE Ratio)?
Asensus Surgical PE Ratio is 0.00000000 now.
What was Asensus Surgical earnings per share over the trailing 12 months (TTM)?
Asensus Surgical EPS is 0 USD over the trailing 12 months.
Which sector does the Asensus Surgical company belong to?
The Asensus Surgical sector is Healthcare.
Asensus Surgical ASXC included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NYSE AMEX COMPOSITE INDEX XAX | 4960.67 USD — |
+0.3
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}